Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07289607

Effect of TECAR on Cervical Radiculopathy

Effect of TECAR Therapy on Proprioception Function in Patients With Cervical Radiculopathy

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Delta University for Science and Technology · Academic / Other
Sex
All
Age
30 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Cervical radiculopathy is characterized by pain, sensory disturbances, and impaired neuromuscular control due to nerve root compression. Proprioception dysfunction is often an overlooked component of this condition and can affect balance, posture, and motor control. TECAR (Transfer of Energy Capacitive and Resistive) therapy is a form of deep heat electrotherapy known to improve tissue perfusion and neuromuscular function. Although TECAR is widely used for pain relief and mobility, its role in improving proprioception remains under-investigated, especially in cervical conditions. This study aims to bridge this gap by assessing proprioceptive outcomes in patients with cervical radiculopathy receiving TECAR therapy.

Detailed description

* Design: Randomized controlled trial. * Groups: * Control group: Receives standard physiotherapy (e.g., cervical traction, exercises). * Experimental group: Receives TECAR therapy in addition to standard physiotherapy. * Duration: 3 sessions per week for 4 weeks. * Outcome Measures: Joint position sense (JPS) using cervical repositioning tests, pain (VAS), functional disability (NDI). * Assessment Times: Baseline and after 4 weeks.

Conditions

Interventions

TypeNameDescription
DEVICETECAR therapyTECAR Therapy A form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.
DEVICESham TECAR therapyTECAR Therapy a form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.

Timeline

Start date
2026-01-01
Primary completion
2026-03-05
Completion
2026-04-05
First posted
2025-12-17
Last updated
2025-12-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07289607. Inclusion in this directory is not an endorsement.